Monograph
M01AC05 - Lornoxicam |
Propably not porphyrinogenic |
PNP |
Rationale
Substrate and inhibitor to CYP 2C9. Compare the other oxicams (probably not porphyrinogenic
Chemical description
Solution for injection; 8-16 mg/d. Analgetic and antipyretic oxicam derivative for short-time use where peroral administration is unsuitable. Totally metabolized by hydroxylation (CYP 2C9). Inhibitor of CYP 2C9.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
United Kingdom
Lornoxicam · Lornoxicam 8mg tablets · Xefo · Xefo 4mg tablets · Xefo 8mg tabletsDenmark
Lornoxicam · Lornoxicam "Takeda" · Xefo · Xefo RapidPoland
Xefo RapidLatvia
Xefo · Xefo Rapid
© NAPOS 2024